Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Colleoni

Showing results (1-10 of 178) with videos related to

Pageof 18
Sort By:
Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica|February 24, 2001
SR141716A induces in rats a behavioral pattern opposite to that of CB1 receptor agonistsB Costa, M Colleoni
European Journal of Pharmacology|April 27, 2000
Changes in rat brain energetic metabolism after exposure to anandamide or Delta(9)-tetrahydrocannabinolB Costa, M Colleoni
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
Neoadjuvant therapy for ER-positive breast cancersM Colleoni, E Montagna
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
Benefits and adverse effects of endocrine therapyM Colleoni, A Giobbie-Hurder
European Journal of Pharmacology|October 10, 1996
Chronic cannabinoid, CP-55,940, administration alters biotransformation in the ratB Costa, D Parolaro, M Colleoni
Tumori|September 1, 1995
Clinical development of new fluoropyrimidines: a major improvement in colorectal cancer treatment?M Colleoni, P Nelli, P Manente
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2006
Primary systemic therapy on local advance breast cancer, where are we going?S Cinieri, L Orlando, M Colleoni
Optics Express|January 22, 2015
Analysis of the THz response of a simple periodic graphite-based structureM P M Colleoni, B Vidal
Psychopharmacology|May 11, 2000
Precipitated and spontaneous withdrawal in rats tolerant to anandamideB Costa, G Giagnoni, M Colleoni
Behavioural Pharmacology|April 26, 2000
SR 141716A, a cannabinoid receptor antagonist, reverses the behavioural effects of anandamide-treated ratsB Costa, S Vailati, M Colleoni
Pageof 18

Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica|February 24, 2001
SR141716A induces in rats a behavioral pattern opposite to that of CB1 receptor agonistsB Costa, M Colleoni
European Journal of Pharmacology|April 27, 2000
Changes in rat brain energetic metabolism after exposure to anandamide or Delta(9)-tetrahydrocannabinolB Costa, M Colleoni
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
Neoadjuvant therapy for ER-positive breast cancersM Colleoni, E Montagna
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
Benefits and adverse effects of endocrine therapyM Colleoni, A Giobbie-Hurder
European Journal of Pharmacology|October 10, 1996
Chronic cannabinoid, CP-55,940, administration alters biotransformation in the ratB Costa, D Parolaro, M Colleoni
Tumori|September 1, 1995
Clinical development of new fluoropyrimidines: a major improvement in colorectal cancer treatment?M Colleoni, P Nelli, P Manente
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2006
Primary systemic therapy on local advance breast cancer, where are we going?S Cinieri, L Orlando, M Colleoni
Optics Express|January 22, 2015
Analysis of the THz response of a simple periodic graphite-based structureM P M Colleoni, B Vidal
Psychopharmacology|May 11, 2000
Precipitated and spontaneous withdrawal in rats tolerant to anandamideB Costa, G Giagnoni, M Colleoni
Behavioural Pharmacology|April 26, 2000
SR 141716A, a cannabinoid receptor antagonist, reverses the behavioural effects of anandamide-treated ratsB Costa, S Vailati, M Colleoni
Pageof 18